Publications & Works

Articles Published in Journals That Entered SCI, SSCI and AHCI Indexes

Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, vol.26, pp.1506-1513, 2021 (Journal Indexed in SCI) Sustainable Development identifier identifier identifier

Multidrug refractory aggressive metastatic TFE3 (+) renal cell carcinoma: A case report.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, no.0, 2021 (Journal Indexed in SCI Expanded) identifier identifier identifier

Efficacy of temozolomide in pretreated patients with metastatic sarcoma.

JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.15, 2021 (Journal Indexed in SCI) identifier

The Prognostic Factors and Outcome of Adult Medulloblastoma: Where We Stand

INTERNATIONAL SURGERY, vol.101, pp.352-360, 2016 (Journal Indexed in SCI) identifier identifier

Associations between clinicopathological prognostic factors and pAkt, pMAPK and topoisomerase II expression in breast cancer

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol.7, no.5, pp.1459-1464, 2014 (Journal Indexed in SCI) Sustainable Development identifier identifier identifier

Serum M65 as a Biomarker for Metastatic Renal Cell Carcinoma

CLINICAL GENITOURINARY CANCER, vol.11, no.3, pp.290-296, 2013 (Journal Indexed in SCI) Sustainable Development identifier identifier identifier

Predictive Value of Marker Half-life in Relapsed and Nonrelapsed Nonseminomatous Germ Cell Testicular Tumor Patients Undergoing Chemotherapy

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, vol.35, no.4, pp.369-372, 2012 (Journal Indexed in SCI) identifier identifier identifier

Does the Timing of Radiotherapy Impact Survival of Glioblastoma Multiforme Patients?

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol.81, no.2, 2011 (Journal Indexed in SCI) identifier

Surveillance results of patients with stage I nonseminomatous testis cancer

JOURNAL OF CLINICAL ONCOLOGY, vol.28, no.15, 2010 (Journal Indexed in SCI) Sustainable Development identifier

Treatment of primary central nervous system lymphoma

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, vol.7, no.3, pp.191-199, 2007 (Journal Indexed in SCI) identifier identifier identifier

HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, vol.25, no.4, pp.515-521, 2006 (Journal Indexed in SCI) Sustainable Development identifier identifier identifier

Does the incidence of anal canal cancers differ in Moslem societies?

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, vol.20, no.1, pp.76, 2005 (Journal Indexed in SCI) Sustainable Development identifier identifier identifier

D-dimer - Can it be a marker for malignant gastric lesions?

ACTA ONCOLOGICA, vol.43, no.8, pp.770-771, 2004 (Journal Indexed in SCI) identifier identifier identifier

Attitude toward genetic testing for cancer risk in Istanbul

GENETIC TESTING, vol.8, no.2, pp.169-173, 2004 (Journal Indexed in SCI) Sustainable Development identifier identifier identifier

Scleredema of Buschke associated with Waldenstrom's macroglobulinaemia

BRITISH JOURNAL OF DERMATOLOGY, vol.143, no.2, pp.450-452, 2000 (Journal Indexed in SCI) identifier identifier identifier

Articles Published in Other Journals

A rare case of ruptured liver metastases from a laryngeal cancer

Radiology Case Reports, vol.16, pp.3330-3335, 2021 (Journal Indexed in ESCI) Sustainable Development

Santral sinir sistemi tümörlerinde immünoonkolojik tedaviler

Türkiye Klinikleri, vol.-, pp.23-27, 2018 (Other Refereed National Journals)

Beyin tümörlerinde hedefe yönelik tedaviler

Türk Nöroşiruji Dergisi, vol.-, pp.218-222, 2017 (Other Refereed National Journals)

Beyin tümörlerinde immünolojik tedavi

Klinik Tıp Bilimleri Dergisi, vol.4, 2016 (Other Refereed National Journals)

Beyin tümörlerinde hedefe yönelik tedaviler

Türkiye Klinikleri, vol.-, pp.14-21, 2016 (Other Refereed National Journals)

Gliom tedavisinde kemoterapi

Kanser Gündemi Dergisi, vol.2, pp.59-61, 2014 (Other Refereed National Journals)

Kadın genital sistem kanserlerinin moleküler biyolojisi ve karsinogenezi

Türkiye Klinikleri, vol.4, pp.1-6, 2011 (Other Refereed National Journals) Sustainable Development

Evre I (T1N0M0) Meme kanseri: Patolojik özellikler ve klinik sonuçlar

TÜRK ONKOLOJİ DERGİSİ, vol.19, pp.53-57, 2004 (Other Refereed National Journals) Sustainable Development

Refereed Congress / Symposium Publications in Proceedings

Yüksek gradli glial tümörlerde yeni yaklaşımlar

6. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 23 - 27 March 2016, pp.72-73

Clinical evaluation of sunitinib in patients with advanced renal cell carcinoma: The Turkish experience

SUNNY-Turkish Council of Higher Education Joint Conference, Albany, United States Of America, 15 - 17 April 2015

Distribution and frequency of BRCA gene mutations in Turkish population including Balkan Turks

AACR Special Conference on Cancer Susceptibility and Cancer Susceptibility Syndromes, California, United States Of America, 29 January - 01 February 2014, vol.74 identifier

Sunitinib in patients with metastatic non-clear renal cell carcinoma: A multicentric retpospective Turkish Oncology Group (TOG) trial.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32 identifier

Investigation of mir-15a/mir-16-1 expression levels in B-cell non-Hodgkin lymphomas.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32 identifier

Effect of increased body mass index on time to tumor progression in metastatic unresectable colorectal cancer patients treated with bevacizumab-based therapy

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31 Sustainable Development identifier

Mesane kanseri tanılı hastalarda organ koruyucu tedavi sonuçlarımız

20. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2013, pp.173 Sustainable Development

Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC)

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 1 - 06 June 2012, vol.30 Sustainable Development identifier

Akciğer kanserinde koagülasyon testlerinin prognostik önemi

4. Tıbbi Onkoloji Kongresi, Antalya, Turkey, 21 - 25 March 2012, pp.150-151 Sustainable Development

Noncutaneous melanoma have distinct features from each other and cutaneous melanoma

2nd Mediterranean Multidisciplinary Oncology Forum, İstanbul, Turkey, 17 - 19 November 2011

Mide kanserinde leptomeningeal metastaz-olgu bildirimi

19. Ulusal Kanser Kongresi, Antalya, Turkey, 20 - 24 April 2011, pp.251 Sustainable Development

OUTCOME OF BRAIN METASTASES FROM COLORECTAL CANCER; A SINGLE INSTITUTE EXPERIENCE

35th European-Society-for-Medical-Oncology (ESMO) Congress, Milan, Italy, 8 - 12 October 2010, vol.21, pp.224 Sustainable Development identifier

Evre I nonseminnmatöz testis kanserlerinde tedavisiz izlem sonuçlarımız

III. Tıbbi Onkoloji Kongresi, Antalya, Turkey, 24 - 28 March 2010, pp.6 Sustainable Development

Paratestiküler rabdomyosarkomlu sekiz vakanın değerlendirilmesi

III. Tıbbi Onkoloji Kongresi, Antalya, Turkey, 24 - 28 March 2010, pp.123

Nefroblastom komponenti içeren testiküler teratom, literatürdeki ilk vaka

III. Tıbbi Onkoloji Kongresi, Antalya, Turkey, 24 - 28 March 2010, pp.126

Mide kanserinde VEGF, HIF-1 alfa, CD34, ekspresyonu ve bu faktörlerin prognostik önemi

I. Tıbbi Onkoloji Kongresi, Antalya, Turkey, 29 March - 02 April 2006, pp.17 Sustainable Development

Outcome of adjuvant treatment in turkish breast cancer (BC) patients (PTS): Single institution experience

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.109 Sustainable Development identifier

The prognostic impact of body mass index (BMI) in early breast cancer (BC) patients (pts).

41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 13 - 17 May 2005, vol.23 Sustainable Development identifier

VEGF, HIF-1 alpha and CD34 expressions in gastric tumors (tms): Relationship with pathological factors and prognostic impact on survival.

41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 13 - 17 May 2005, vol.23 identifier

Clinical and pathological characteristics of early breast cancer (EBC) patients < 35 years old.

41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 13 - 17 May 2005, vol.23 Sustainable Development identifier

Outcome of adjuvant treatment in elderly Turkish breast cancer patients.

41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 13 - 17 May 2005, vol.23 Sustainable Development identifier

FOLFOX4 in metastatic colorectal cancer (MCRC) patients who progressed after infusional 5-FU/irinotecan based combination regimens.

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America, 5 - 08 June 2004, vol.22 Sustainable Development identifier

Human papilloma virus: Is it a new etiological factor in breast cancer?

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America, 5 - 08 June 2004, vol.22 Sustainable Development identifier

Prognostic value of thymidylate synthase and cox-2 expression in colorectal cancer patients' tumors.

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America, 5 - 08 June 2004, vol.22 Sustainable Development identifier

Paclitaxel (P) (day 1 and 8) and carboplatin (C) given on every 3 weeks in advanced (stage III-IV) non-small cell lung cancer (NSCLC).

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America, 5 - 08 June 2004, vol.22 Sustainable Development identifier

Is the incidence of anal canal cancers different in Moslem societies?

40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America, 5 - 08 June 2004, vol.22 Sustainable Development identifier

Mantle cell lymphoma presenting as abreast mass

15th ICACT, Paris, France, 9 - 12 February 2004, vol.-

Premenopozal meme kanseri hastalarında kemoterapiye bağlı amenore insidansı ve prognostik rolü

VII. Ulusal Meme Hatalıkları Kongresi, Antalya, Turkey, 16 - 19 October 2003, pp.170 Sustainable Development

Evre III over kanserinde kemoterapi sonuçlarımız

XV. Ulusal Kanser Kongresi, Antalya, Turkey, 23 - 27 April 2003, vol.-, pp.112 Sustainable Development

Attitude towards genetic testing in Turkish society

11th European Cancer Conference, Lizbon, Portugal, 21 - 25 October 2001, vol.-

Plasma D-dimer levels in patients with benign and malignant gastric lesions

European Society of Medical Oncology, Hamburg, Germany, 13 - 17 October 2000, vol.-

Books & Book Chapters

Gebelikte Beyin Tümörlerinin Sistemik Tedavisi

in: Gebelikte Kanser Tedavisi, Çiçin İ., Kılıçkap S., Saip P., Güler N., Editor, Güneş Tıp Kitabevleri, Ankara, pp.91-96, 2017 Sustainable Development

Kanserli Hastada Kemik Sorunları

in: Kanser Hastasına Yaklaşım, Mandel NM., Onat H., Editor, Nobel Tıp Kitabevleri, İstanbul, pp.257-269, 2012 Sustainable Development

Farmakogenomik

in: Kanser Hastasına Yaklaşım, Mandel NM., Onat H., Editor, Nobel Tıp Kitabevleri, İstanbul, pp.113-122, 2012 Sustainable Development